HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-FEB-23 8G6T TITLE BROMODOMAIN OF CBP LIGANDED WITH INHIBITOR ICBP2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CREB-BINDING PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: HISTONE LYSINE ACETYLTRANSFERASE CREBBP,PROTEIN-LYSINE COMPND 5 ACETYLTRANSFERASE CREBBP; COMPND 6 EC: 2.3.1.48,2.3.1.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CREBBP, CBP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3 RIL; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS BROMODOMAIN, COMPLEX, TRANSCRIPTION, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.SCHONBRUNN,M.BIKOWITZ REVDAT 2 22-MAY-24 8G6T 1 JRNL REVDAT 1 21-FEB-24 8G6T 0 JRNL AUTH N.A.M.SHENDY,M.BIKOWITZ,L.H.SIGUA,Y.ZHANG,A.MERCIER, JRNL AUTH 2 Y.KHASHANA,S.NANCE,Q.LIU,I.M.DELAHUNTY,S.ROBINSON,V.GOEL, JRNL AUTH 3 M.G.REES,M.A.RONAN,T.WANG,M.KOCAK,J.A.ROTH,Y.WANG, JRNL AUTH 4 B.B.FREEMAN,B.A.ORR,B.J.ABRAHAM,M.F.ROUSSEL,E.SCHONBRUNN, JRNL AUTH 5 J.QI,A.D.DURBIN JRNL TITL GROUP 3 MEDULLOBLASTOMA TRANSCRIPTIONAL NETWORKS COLLAPSE JRNL TITL 2 UNDER DOMAIN SPECIFIC EP300/CBP INHIBITION. JRNL REF NAT COMMUN V. 15 3483 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38664416 JRNL DOI 10.1038/S41467-024-47102-0 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1-4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.65 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.050 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.4 REMARK 3 NUMBER OF REFLECTIONS : 44542 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2226 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.6500 - 4.4100 0.91 2633 138 0.1986 0.2384 REMARK 3 2 4.4100 - 3.5000 0.95 2717 143 0.1621 0.1890 REMARK 3 3 3.5000 - 3.0600 0.90 2625 138 0.1950 0.1930 REMARK 3 4 3.0600 - 2.7800 0.89 2588 136 0.1992 0.2238 REMARK 3 5 2.7800 - 2.5800 0.93 2691 142 0.2006 0.2332 REMARK 3 6 2.5800 - 2.4300 0.94 2720 143 0.1979 0.2402 REMARK 3 7 2.4300 - 2.3100 0.94 2713 142 0.1942 0.2277 REMARK 3 8 2.3000 - 2.2000 0.93 2763 146 0.1892 0.2209 REMARK 3 9 2.2000 - 2.1200 0.82 2349 123 0.1889 0.2555 REMARK 3 10 2.1200 - 2.0500 0.90 2587 137 0.1944 0.2420 REMARK 3 11 2.0500 - 1.9800 0.91 2652 139 0.1986 0.2374 REMARK 3 12 1.9800 - 1.9300 0.92 2658 140 0.1998 0.2525 REMARK 3 13 1.9300 - 1.8800 0.92 2659 140 0.1902 0.2540 REMARK 3 14 1.8800 - 1.8300 0.94 2692 142 0.1903 0.2224 REMARK 3 15 1.8300 - 1.7900 0.92 2692 141 0.1909 0.2406 REMARK 3 16 1.7900 - 1.7500 0.89 2577 136 0.1876 0.2015 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 NULL REMARK 3 ANGLE : 1.110 NULL REMARK 3 CHIRALITY : 0.060 575 REMARK 3 PLANARITY : 0.008 723 REMARK 3 DIHEDRAL : 8.057 534 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 8.2996 -10.3792 13.1630 REMARK 3 T TENSOR REMARK 3 T11: 0.1003 T22: 0.1256 REMARK 3 T33: 0.1526 T12: -0.0069 REMARK 3 T13: -0.0008 T23: 0.0070 REMARK 3 L TENSOR REMARK 3 L11: 0.1299 L22: 0.2204 REMARK 3 L33: 0.4083 L12: -0.0096 REMARK 3 L13: 0.0749 L23: -0.0757 REMARK 3 S TENSOR REMARK 3 S11: 0.0091 S12: -0.0174 S13: 0.0058 REMARK 3 S21: 0.0051 S22: 0.0060 S23: 0.0343 REMARK 3 S31: 0.0192 S32: -0.0246 S33: -0.0141 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8G6T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1000272300. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-OCT-21 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JAN 10, 2022 REMARK 200 DATA SCALING SOFTWARE : XSCALE JAN 10, 2022 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44573 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 33.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.4 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.20.1-4487 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.01 M NICKEL(II) CHLORIDE REMARK 280 HEXAHYDRATE, 0.1 M TRIS PH 8.5, 20% W/V POLYETHYLENE GLYCOL REMARK 280 MONOMETHYL ETHER 2,000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 1082 REMARK 465 LYS A 1083 REMARK 465 LYS B 1082 REMARK 465 LYS B 1083 REMARK 465 LYS C 1082 REMARK 465 LYS C 1083 REMARK 465 LYS D 1082 REMARK 465 LYS D 1083 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 1358 O HOH B 1363 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NI C1202 NI REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP C1127 OD1 REMARK 620 2 HOH C1312 O 68.0 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NI D1202 NI REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP D1127 OD1 REMARK 620 2 HOH D1355 O 106.2 REMARK 620 3 HOH D1366 O 81.8 169.7 REMARK 620 4 HOH D1379 O 106.3 61.6 123.2 REMARK 620 5 HOH D1387 O 128.7 118.9 51.3 115.6 REMARK 620 N 1 2 3 4 DBREF 8G6T A 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 DBREF 8G6T B 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 DBREF 8G6T C 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 DBREF 8G6T D 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 SEQRES 1 A 116 LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN ALA LEU SEQRES 2 A 116 MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP PRO GLU SEQRES 3 A 116 SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN LEU LEU SEQRES 4 A 116 GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN PRO MET SEQRES 5 A 116 ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR GLY GLN SEQRES 6 A 116 TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL TRP LEU SEQRES 7 A 116 MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS THR SER SEQRES 8 A 116 ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU VAL PHE SEQRES 9 A 116 GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU GLY SEQRES 1 B 116 LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN ALA LEU SEQRES 2 B 116 MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP PRO GLU SEQRES 3 B 116 SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN LEU LEU SEQRES 4 B 116 GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN PRO MET SEQRES 5 B 116 ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR GLY GLN SEQRES 6 B 116 TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL TRP LEU SEQRES 7 B 116 MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS THR SER SEQRES 8 B 116 ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU VAL PHE SEQRES 9 B 116 GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU GLY SEQRES 1 C 116 LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN ALA LEU SEQRES 2 C 116 MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP PRO GLU SEQRES 3 C 116 SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN LEU LEU SEQRES 4 C 116 GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN PRO MET SEQRES 5 C 116 ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR GLY GLN SEQRES 6 C 116 TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL TRP LEU SEQRES 7 C 116 MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS THR SER SEQRES 8 C 116 ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU VAL PHE SEQRES 9 C 116 GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU GLY SEQRES 1 D 116 LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN ALA LEU SEQRES 2 D 116 MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP PRO GLU SEQRES 3 D 116 SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN LEU LEU SEQRES 4 D 116 GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN PRO MET SEQRES 5 D 116 ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR GLY GLN SEQRES 6 D 116 TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL TRP LEU SEQRES 7 D 116 MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS THR SER SEQRES 8 D 116 ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU VAL PHE SEQRES 9 D 116 GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU GLY HET YRI A1201 39 HET YRI B1201 39 HET YRI C1201 39 HET NI C1202 1 HET YRI D1201 39 HET NI D1202 1 HETNAM YRI (6S)-1-(3,4-DIBROMOPHENYL)-6-{(5M)-5-(3,5-DIMETHYL-1,2- HETNAM 2 YRI OXAZOL-4-YL)-1-[(1S,4R)-4-METHOXYCYCLOHEXYL]-1H- HETNAM 3 YRI BENZIMIDAZOL-2-YL}PIPERIDIN-2-ONE HETNAM NI NICKEL (II) ION FORMUL 5 YRI 4(C30 H32 BR2 N4 O3) FORMUL 8 NI 2(NI 2+) FORMUL 11 HOH *304(H2 O) HELIX 1 AA1 LYS A 1086 ARG A 1103 1 18 HELIX 2 AA2 SER A 1108 ARG A 1112 5 5 HELIX 3 AA3 ASP A 1116 GLY A 1121 1 6 HELIX 4 AA4 ASP A 1124 VAL A 1129 1 6 HELIX 5 AA5 ASP A 1134 GLY A 1145 1 12 HELIX 6 AA6 GLU A 1149 ASN A 1168 1 20 HELIX 7 AA7 SER A 1172 GLY A 1197 1 26 HELIX 8 AA8 LYS B 1086 GLN B 1104 1 19 HELIX 9 AA9 SER B 1108 ARG B 1112 5 5 HELIX 10 AB1 ASP B 1116 GLY B 1121 1 6 HELIX 11 AB2 ASP B 1124 VAL B 1129 1 6 HELIX 12 AB3 ASP B 1134 THR B 1144 1 11 HELIX 13 AB4 GLU B 1149 ASN B 1168 1 20 HELIX 14 AB5 SER B 1172 GLY B 1197 1 26 HELIX 15 AB6 LYS C 1086 ARG C 1103 1 18 HELIX 16 AB7 SER C 1108 ARG C 1112 5 5 HELIX 17 AB8 ASP C 1116 GLY C 1121 1 6 HELIX 18 AB9 ASP C 1124 VAL C 1129 1 6 HELIX 19 AC1 ASP C 1134 THR C 1144 1 11 HELIX 20 AC2 GLU C 1149 ASN C 1168 1 20 HELIX 21 AC3 SER C 1172 GLY C 1197 1 26 HELIX 22 AC4 LYS D 1086 ARG D 1103 1 18 HELIX 23 AC5 SER D 1108 ARG D 1112 5 5 HELIX 24 AC6 ASP D 1116 GLY D 1121 1 6 HELIX 25 AC7 ASP D 1124 VAL D 1129 1 6 HELIX 26 AC8 ASP D 1134 THR D 1144 1 11 HELIX 27 AC9 GLU D 1149 ASN D 1168 1 20 HELIX 28 AD1 SER D 1172 LEU D 1196 1 25 LINK OD1 ASP C1127 NI NI C1202 1555 1555 2.71 LINK NI NI C1202 O HOH C1312 1555 1555 1.93 LINK OD1 ASP D1127 NI NI D1202 1555 1555 2.19 LINK NI NI D1202 O HOH D1355 1555 1555 2.35 LINK NI NI D1202 O HOH D1366 1555 1555 2.59 LINK NI NI D1202 O HOH D1379 1555 1555 2.46 LINK NI NI D1202 O HOH D1387 1555 1555 2.79 CISPEP 1 ASP A 1105 PRO A 1106 0 6.09 CISPEP 2 ASP B 1105 PRO B 1106 0 4.99 CISPEP 3 ASP C 1105 PRO C 1106 0 4.01 CISPEP 4 ASP D 1105 PRO D 1106 0 10.10 CRYST1 34.580 55.910 69.670 93.06 103.16 106.53 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028918 0.008583 0.007911 0.00000 SCALE2 0.000000 0.018657 0.002381 0.00000 SCALE3 0.000000 0.000000 0.014860 0.00000